7mng: Difference between revisions
Jump to navigation
Jump to search
New page: ==Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with Covalent Inhibitor VBY-825 (Partial Occupancy)== <StructureSection load='7mng' size='340' side='right'caption... |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with Covalent Inhibitor VBY-825 (Partial Occupancy)== | ==Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with Covalent Inhibitor VBY-825 (Partial Occupancy)== | ||
<StructureSection load='7mng' size='340' side='right'caption='[[7mng]]' scene=''> | <StructureSection load='7mng' size='340' side='right'caption='[[7mng]], [[Resolution|resolution]] 1.70Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7MNG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7MNG FirstGlance]. <br> | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7MNG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7MNG FirstGlance]. <br> | ||
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7mng FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7mng OCA], [https://pdbe.org/7mng PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7mng RCSB], [https://www.ebi.ac.uk/pdbsum/7mng PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7mng ProSAT]</span></td></tr> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.7Å</td></tr> | ||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=ZL7:(2R,3S)-N-cyclopropyl-3-{[(2R)-3-(cyclopropylmethanesulfonyl)-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanoyl]amino}-2-hydroxypentanamide+(non-preferred+name)'>ZL7</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7mng FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7mng OCA], [https://pdbe.org/7mng PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7mng RCSB], [https://www.ebi.ac.uk/pdbsum/7mng PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7mng ProSAT]</span></td></tr> | |||
</table> | </table> | ||
__TOC__ | __TOC__ | ||
Latest revision as of 16:43, 6 November 2024
Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with Covalent Inhibitor VBY-825 (Partial Occupancy)Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in Complex with Covalent Inhibitor VBY-825 (Partial Occupancy)
Structural highlights
|
| ||||||||||||||||||